
CVS Health Corporation (CVS)
$
76.69
-0.63 (-0.82%)
Key metrics
Financial statements
Free cash flow per share
6.1472
Market cap
97.6 Billion
Price to sales ratio
0.2427
Debt to equity
1.2444
Current ratio
0.8424
Income quality
3.6150
Average inventory
19.1 Billion
ROE
0.0234
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
CVS Health Corporation provides a comprehensive range of health services across the United States, demonstrating its commitment to meet the diverse needs of its clientele. The company’s Health Care Benefits segment offers a variety of health insurance products, including traditional, voluntary, and consumer-directed options, aimed at employer groups, individuals, college students, part-time workers, and various other organizations such as health plans and governmental units. With a net income ratio of 0.00 reflecting its profitability margin, CVS Health showcases its financial strength through an operating income of $10,385,000,000.00 indicative of its core operational earnings. The company earned an interest income of $0.00 showcasing its financial investments and ability to generate revenue outside its primary services. Additionally, the gross profit stands at $55,362,000,000.00 highlighting the effectiveness of its core operations. In its Pharmacy Services segment, CVS Health offers pharmacy benefit management solutions, including plan design, formulary management, and specialty pharmacy services, catering to a wide range of clients from employers to individuals. This segment plays a crucial role in managing medication needs and delivering tailored health care solutions. As of December 31, 2021, CVS Health operated approximately 9,900 retail locations and 1,200 MinuteClinic facilities, further affirming its extensive presence in the health care market. Within the financial landscape, CVS Health's stock is identified with the symbol 'CVS', attracting a variety of investors. The stock is affordable at $74.92 suitable for budget-conscious investors, while its high average trading volume of 8,406,913.00 indicates strong liquidity. With a large market capitalization of $97,565,784,900.00 the company stands as a dominant player in the health services industry, contributing significantly to the overall market landscape. As it belongs to the Healthcare sector, CVS Health is instrumental in driving innovation and growth, shaping the future of health care delivery and access. This strategic positioning not only enhances its market influence but also ensures it remains a pivotal force within the evolving health care industry.
Investing in CVS Health Corporation (CVS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict CVS Health Corporation stock to fluctuate between $58.35 (low) and $85.15 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-02-20, CVS Health Corporation's market cap is $97,565,784,900, based on 1,272,210,000 outstanding shares.
Compared to Eli Lilly & Co., CVS Health Corporation has a Lower Market-Cap, indicating a difference in performance.
CVS Health Corporation pays dividends. The current dividend yield is 3.22%, with a payout of $0.67 per share.
To buy CVS Health Corporation (CVS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CVS. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
CVS Health Corporation's last stock split was 2:1 on 2005-06-07.
Revenue: $402,067,000,000 | EPS: $1.40 | Growth: -61.75%.
Visit https://www.cvshealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $111.25 (2022-02-08) | All-time low: $43.56 (2024-12-23).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

zacks.com
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

globenewswire.com
Mike Rivera Of Naples Fl Congratulates Hendricks Commercial Properties on Exceptional Return From Sale of Marco Island's CVS-Anchored Island Plaza Mike Rivera Of Naples Fl Congratulates Hendricks Commercial Properties on Exceptional Return From Sale of Marco Island's CVS-Anchored Island Plaza

benzinga.com
CVS Health Corp. (NYSE: CVS) reported sales of $105.69 billion, beating the consensus of $103.59 billion on Tuesday.

zacks.com
CVS beats Q4 earnings and revenue estimates, but higher costs squeeze margins. Shares slip pre-market despite upbeat 2026 EPS guidance.

seekingalpha.com
CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript

zacks.com
CVS Health (CVS) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $1.19 per share a year ago.

247wallst.com
CVS Health (NYSE: CVS) delivered a solid revenue beat in Q4 2025, though adjusted earnings declined year-over-year despite exceeding Wall Street expectations.
barrons.com
CVS Health earnings came in ahead of analyst forecasts but the company is concerned about Medicare rates.

marketwatch.com
The healthcare giant saw its revenue jump 8% in the fourth quarter
See all news